175
Participants
Start Date
January 29, 2019
Primary Completion Date
December 14, 2021
Study Completion Date
December 14, 2021
BRAHMS CgA II KRYPTOR
"The BRAHMS CgA II KRYPTOR kit is an automated immunofluorescent assay for the quantitative determination of the concentration of CgA in human serum.~The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in patients with GEP-NETs (grade 1 and grade 2).~Serial testing for patient BRAHMS CgA II KRYPTOR assay values should be used in conjunction with other clinical methods for monitoring GEP-NETs (grade 1 and grade 2)."
Mayo Clinic, Rochester
The University of Texas MD Anderson Cancer Center, Houston
Stanford University Medical Center, Palo Alto
Charité - Universitätsmedizin Berlin, Berlin
Brahms AG
INDUSTRY